J Haem Pract 2015; 2(2):8-10. doi: 10.17225/jhp00050
Arthur Bloom Haemophilia Centre,
School of Medicine, Cardiff University, University Hospital of Wales, Cardiff, CF14 4XN, UK.
Advances in the understanding of haemophilia require effective collaboration, both at the national and international levels. Such collaborations are currently playing a major role in elucidating the natural history of acquired haemophilia, and also in clarifying the issue of product-related inhibitor development in previously untreated patients with haemophilia.
Photograph of Arthur Bloom © Cardiff University Library, Cochrane Archive, University Hospital Llandough
Knoebl P, Marco P, Baudo F, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost 2012; 10(4): 622-31. doi: 10.1111/j.1538-7836.2012.04654.x.
Baudo F, Collins P, Huth-Kühne A, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012; 120(1):39-46. doi: 10.1182/blood-2012-02-408930.
Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012; 120(1): 47-55. doi: 10.1182/blood-2012-02-409185
Tengborn L, Baudo F, Huth-Kühne A, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG 2012; 119(12):1529-37. doi: 10.1111/j.1471-0528.2012.03469.x.
van den Berg HM, Gouw SC, van der Bom JG, et al. Factor VIII products and inhibitors in severe hemophilia A. N Engl J Med 2013; 368(15): 1457. doi: 10.1056/NEJMc1301995.
Collins PW, Palmer BP, Chalmers EA, et al. Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood 2014; 124(23): 3389-97. doi: 10.1182/blood-2014-07-580498.
Calvez T, Chambost H, Claeyssens-Donadel S, et al. Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. Blood 2014; 24(23): 3398-408. doi: 10.1182/blood-2014-07-586347.